Genmab — Marts 2024

[lahn1]

Jørgen dig og din value trap. Der er ingen kriterier for en value trap som opfyldes af Gmab. Godt være man kan tabe penge på gmab, men det sgu ikke fordi den er en value trap.

[JørgenVarnæs]

Så længe du overvejer muligheden, min ven, så er jeg glad

[JørgenVarnæs]

…men GEN kan sagtens være moderen til alle value traps

[JørgenVarnæs]

Davrin - du er en vinder for mig. Men husk at være kritisk

[Darvin]

[Helge_LarsenPI-redaktør]

Godmorgen

[Stroka]

God morgen

[bibob]

God morgen og god påske.

[E_L]

Successful treatment of scleromyxoedema with daratumumab https://twitter.com/BrJHaem/status/1773312588996079630

[E_L]

Pfizer stops one of two Phase 3 trials for sickle cell drug, still plans to seek approval in 2026 - inclacumab - https://endpts.com/pfizer-stops-one-of-two-phase-3-trials-for-sickle-cell-drug-still-plans-to-seek-approval-in-2026/

[E_L]

this was last summer - 2/8 09:20
af E L
Both Inclacumab stopped recruiting. (link) (link) Not sure if Pfizer will continue with these --> so we knew recruitment was stopped, now we know they still look for approval

[Helge_LarsenPI-redaktør]

Kort video - Ugekommentar #122 Novo, Gubra, Zealand Pharma, Bavarian, Genmab, Ultimovacs, Anavex, Teva https://www.proinvestor.com/boards/119556

[gentogen]

The phase 3 that stopped recruitment last summer is in fact fully recruited by now (240 patients as originally planned)

[E_L]

Genmab expands US headquarters, plots 300 hires amid launch of AbbVie-partnered lymphoma med Epkinly https://www.fiercepharma.com/pharma/genmab-nabs-lease-us-expansion-it-looks-boost-marketing-its-abbvie-partnered-lymphoma-med

[Klarussen]

Thanks E.L.

[Sukkeralf]

Just a moment...

(www.fiercebiotech.com)